Corrigendum to "Prognostic and predictive impact of beta-2 adrenergic receptor expression in HER2-positive breast cancer" [Clin Breast Cancer 2020; 20:262-73.e7].

Caparica, Rafael; Richard, François; Brandão, Mariana; Awada, Ahmad; Sotiriou, Christos; de Azambuja, Evandro

Caparica, Rafael; Richard, François; Brandão, Mariana; Awada, Ahmad; Sotiriou, Christos; de Azambuja, Evandro.

Afiliação

Caparica R; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Electronic address: rafael.caparica@bordet.be.
Richard F; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.
Brandão M; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
Awada A; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
de Azambuja E; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.

Clin Breast Cancer ; 23(5): e281-e284, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37183094

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google